5 Results for "

intravitreally

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "intravitreally" in MCE Product Catalog:

Art. -Nr.: HY-P99830
CAS. Nr.: 1227158-72-6
Synonyms: KH902
Conbercept (KH902) is a recombinant fusion protein composed of VEGFR-1 (second domain) and VEGFR-2 (third and fourth domains) regions fused to human IgG1 Fc. Conbercept is a VEGF inhibitor (IC50 = 8.8 pM) and is a soluble receptor decoy that blocks all isoforms of VEGF-A (Kd = 0.5 pM), VEGF-B (Kd = 8 pM), VEGF-C, and PlGF (Kd = 5 pM). Conbercept has anti-inflammatory effects, can lower the levels of VEGF, TNF-α and IL-6, and reduce the infiltration of inflammatory cells. Conbercept decreases tumor growth in several oncology studies. Conbercept can be used for various eye diseases such as polypoidal choroidal vasculopathy (PCV), diabetic macular edema (DME) and pathologic myopia choroidal neovascularization (pmCNV) .
loading...
    loading...
Art. -Nr.: HY-16387
CAS. Nr.: 854514-88-8
Target:  

VEGFR

Forschungsgebiete:  

Others

PF-00337210 is a potent and selective inhibitor of VEGFRs, designed for treating age-related macular degeneration via intravitreal injection. The formulation strategy focused on developing an ophthalmic solution that would precipitate upon injection into the vitreous, ensuring sustained drug delivery. Challenges included maintaining low dosing volumes, selecting safe excipients for intravitreal use, and addressing the drug's unique physicochemical properties. The final formulation, an isotonic solution in a citrate-buffered vehicle with NaCl, demonstrated stability, potency, and recovery through intravitreal dosing syringes. It formed a depot upon injection into vitreous humor, representing a novel nonpolymeric in situ-forming depot formulation for intravitreal drug delivery .
loading...
    loading...
Art. -Nr.: HY-P991886

Target:  

Complement System

Forschungsgebiete:  

Neurological Disease

ANX-M1 is a blood-brain barrier-permeable anti-C1q antibody. ANX-M1 can slow down the progression of retinal degeneration following photo-oxidative damage. ANX-M1 has been incorporated into nanocarriers to evaluate its brain delivery efficacy in a mouse model of Alzheimer's disease. ANX-M1 is applicable for research on age-related macular degeneration and Alzheimer's disease [1] .
loading...
    loading...
Art. -Nr.: HY-P991030
CAS. Nr.: 2839527-15-8
Synonyms: OG-2072

Target:  

Interleukin Related

Forschungsgebiete:  

Inflammation/Immunology

Tabirafusp alfa (OG-2072, KSI-101) is a bispecific antibody trap fusion protein that inhibits IL-6 and VEGF. Tabirafusp alfa is a first-in-class, high-strength intravitreal biologic designed to target IL-6 mediated inflammation and VEGF-mediated vascular permeability in macular edema secondary to inflammation (MESI) .
loading...
    loading...
Art. -Nr.: HY-P992142
CAS. Nr.: 3050549-24-8
Synonyms: ANX-007

Target:  

Complement System

Forschungsgebiete:  

Metabolic Disease

Vonaprument is an intravitreally injected C1q antibody fragment, which is a human monoclonal antibody. Vonaprument is applicable to research related to age-related macular degeneration .
loading...
    loading...